Home Credit Ratings and Research Fitch Research GSK PLC

Fitch Ratings: Tesaro Buy to Boost GSK's Position in Oncology Race

Published Dec 12, 2018

2021 words — Published Dec 12, 2018

Price US$ 149.00 | Buy this Report Now

About This Report

Brief Excerpt:

Fitch Ratings: Tesaro Buy to Boost GSK's Position in Oncology Race 12 Dec 2018 12:33 PM (EST) {COMPANYDESC_ORIGIN_PUBDATE}: The acquisition of Tesaro by GlaxoSmithKline PLC (GSK, A/Negative) for GBP4 billion (USD5.1 billion) will reinforce...

Report Type:

Press Release

Company(ies)

GSK PLC , GlaxoSmithKline Finance PLC , Glaxosmithkline Capital Plc , Glaxosmithkline Capital Inc.

Ticker(s)

GSK

Issuer

GSK PLC

Format:

HTML

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author

Cite this Report


MLA:	Fitch Research. "Fitch Ratings: Tesaro Buy to Boost GSK's Position in Oncology Race" Dec 12, 2018. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Ratings-Tesaro-Buy-to-Boost-GSK-s-Position-in-Oncology-Race-1051285_pr_frame>

APA:	Fitch Research. (). Fitch Ratings: Tesaro Buy to Boost GSK's Position in Oncology Race Dec 12, 2018. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Ratings-Tesaro-Buy-to-Boost-GSK-s-Position-in-Oncology-Race-1051285_pr_frame>

US$ 149.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.